In addition, when compared with other MDM2 antagonists RG7388 and Nutlin-3, which have demonstrated significant efficacy in a variety of cancer types in vitro [45–47], SAR405838 had shown a similar inhibitory effect on NB cells. The gene discussed is MDM2; the disease is cancer.